Healthcare news on August 1, 2026

1. 0111:30 UTC

   FDA is deciding on Moderna's mRNA flu vaccine

   6 outlets · first: kunc.org Regulation

   Machine summary The FDA is deciding on Moderna’s mRNA flu vaccine. An advisory panel backed approval. HHS Secretary RFK Jr. has expressed political skepticism, and the agency previously reversed a decision.

   1. Moderna President Stephen Hoge described the initial refusal as a ‘shock,’ noting the FDA had previously indicated it would conduct a review.

   Reported by kunc.org, wcsufm.org, wmra.org, news.wjct.org, wdiy.org and wuwf.org.

   • Moderna
   • mRNA

2. 0214:45 UTC

   Dr Reddy's rituximab biosimilar approved in US, already in 25+ global markets

   2 outlets · first: Times of India Regulation

   Machine summary Fresenius Kabi will commercialize the product, which is already available in over 25 markets globally.

   1. The biosimilar is indicated for B-cell malignancies (non-Hodgkin lymphoma, chronic lymphocytic leukaemia) and autoimmune conditions (rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis).
   2. Fresenius Kabi holds exclusive US commercialization rights under an agreement with Dr Reddy's; launch timing and financial details were not disclosed.
   3. The product is already commercialized in India, the EU, the UK, and over 25 emerging markets, with additional approvals in Switzerland and Canada.
   4. The approval was supported by analytical, non-clinical, and clinical evidence demonstrating the biosimilar is highly similar to Rituxan, with no clinically meaningful differences in safety, purity, or potency.

   Reported by Times of India and The Hindu - Business Line.

   • Rituximab biosimilar
   • Fresenius Kabi
   • Rituxan (rituximab)

3. 0314:15 UTC

   Beijing hospital deploys three-arm robotic system for IV admixture

   2 outlets · first: english.news.cn Health IT

   Machine summary Xinhua reported that a Beijing hospital is using a three-arm robotic system developed by Meilan PIVAS Robots Co., Ltd. to prepare intravenous admixtures, with the arms handling the infusion bag, vial and syringe. A pharmacist described the machine as a "hand-saving partner," and company founder Fu Xiaoyang said it can reduce repetitive manual work and human error and free pharmacists for other tasks.

   1. A Beijing hospital has deployed a three-armed robotic system from Meilan PIVAS Robots Co., Ltd. to automate IV admixture preparation, with one arm for the IV bag, one for the vial, and one for the syringe.
   2. Pharmacist Chen Tingyu, a user of the system, calls it her 'hand-saving partner' and notes the robot frees staff from repetitive labor, reducing human error.
   3. Founder Fu Xiaoyang, a former pharmacy professional, designed the system after first-hand experience with the physical toll and inefficiency of manual IV preparation.
   4. The system uses digital logging and chip-based item identification, allowing a pharmacist to load materials and trigger the automated mixing process with a screen tap, keeping the pharmacist in a supervisory role.

   Reported by english.news.cn and laosnews.net (Big News Network).

   • Meilan PIVAS Robots Co., Ltd.
   • Beijing hospital (unnamed)

4. 0408:00 UTC

   British Heart Foundation highlights 10 UK 'defibrillator deserts'

   2 outlets · first: Wales Online Medical devices

   Machine summary Key facts from the reports:

   1. The British Heart Foundation said 10 areas across the UK are "defibrillator deserts".
   2. BHF's Sam Kennard said: "When someone has a cardiac arrest, every second counts, and quick access to a defibrillator gives someone the best possible chance of survival before emergency help arrives."

   Reported by Wales Online and Cambridge News.

   • British Heart Foundation

Each summary and its key facts are a machine summary of the reports linked under it; the outlets, times and counts come from those reports' own records. How a rundown is built.